Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension

References

• American Heart Association and A. S. AssociationHeart disease and stroke statistics - 2006 update [online]2006 Accessed 3 March 2006. URL: http://www.americanheart.org
   Google Scholar
• BallKJWilliamsPAStumpeKORelative efficacy of an angiotensin II antagonist compared with other antihypertensive agents. Olmesartan medoxomil versus antihypertensivesJ Hypertens200119Suppl 1S4956
   Google Scholar
• BenzJRBlackHRGraffAValsartan and hydrochlorothiazide in patients with essential hypertension. A multiple dose, double-blind placebo controlled trial comparing combination therapy with monotherapyJ Hum Hypertens19981286169883710
   PubMed Web of Science ®Google Scholar
• BrownCLBackhouseCIGrippatJCThe effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin-angiotensin system in hypertensive subjectsEur J Clin Pharmacol199039327322076713
   PubMed Web of Science ®Google Scholar
• BrunnerHRNussbergerJRelevance of clinical pharmacological models for the evaluation of therapeutic dose range of an AT1-receptor antagonistJ Hypertens200119Suppl 1S1520
   Google Scholar
• BurnierMAngiotensin II type 1 receptor blockersCirculation20011039041211171802
   PubMed Web of Science ®Google Scholar
• CaroJJSpeckmanJLSalasMEffect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice dataCMAJ19991604169934342
   PubMed Web of Science ®Google Scholar
• CarterBLErnstMECohenJDHydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeabilityHypertension2004434914638621
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHRSeventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension20034212065214656957
   PubMed Web of Science ®Google Scholar
• ChrysantSGAntihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter studyArch Intern Med1994154737438147677
   PubMed Web of Science ®Google Scholar
• ChrysantSGWeberMAWangACEvaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazideAm J Hypertens2004172525915001200
   PubMed Web of Science ®Google Scholar
• ConlinPRSpenceJDWilliamsBAngiotensin II antagonists for hypertension: are there differences in efficacy?Am J Hypertens2000134182610821345
   PubMed Web of Science ®Google Scholar
• DahlofBDevereuxRBKjeldsenSECardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololLancet2002359995100311937178
   PubMed Web of Science ®Google Scholar
• Daiichi Sankyo, Inc.2005 Benicar HCT Prescribing Information
   Google Scholar
• European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertensionJ Hypertens20032110115312777938
   PubMed Web of Science ®Google Scholar
• IzzoJLLevyDJr.BlackHRClinical Advisory Statement. Importance of systolic blood pressure in older AmericansHypertension2000351021410818056
   PubMedGoogle Scholar
• KjeldsenSEOsIHoieggenAFixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazideAm J Cardiovasc Drugs20055172215631534
   PubMedGoogle Scholar
• KocharMGuthrieRTriscariJMatrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertensionAm J Hypertens19991279780510480473
   PubMed Web of Science ®Google Scholar
• KoikeHSadaTTriscariJIn vitro and in vivo pharmacology of olmesartan medoxomil, an angiotensin II type AT1 receptor antagonistJ Hypertens200119SupplS314
   Google Scholar
• KreutzRBolbrinkerJHuberTPharmacokinetics of olmesartan plus hydrochlorothiazide combination in healthy subjectsClin Drug Invest2006262934
   PubMed Web of Science ®Google Scholar
• LacourciereYNeutelJMSchumacherHComparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trialsClin Ther200527179580516368450
   PubMed Web of Science ®Google Scholar
• LaeisPPuchlerKKirchWThe pharmacokinetic and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interactionJ Hypertens200119SupplS2132
   PubMedGoogle Scholar
• ManciaGBombelliMLanzarottiASystolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population. Pressioni Arteriose Monitorate E Loro AssociazioniArch Intern Med2002162582611871927
   PubMedGoogle Scholar
• ManolisA JGrossmanEJelakovicBEffects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertensionClin Ther200022118620311110230
   PubMed Web of Science ®Google Scholar
• McGillJBReillyPATelmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trialClin Ther2001238335011440284
   PubMed Web of Science ®Google Scholar
• MeredithPAAngiotensin II receptor antagonists alone and combined with hydrochlorothiazide: potential benefits beyond the antihypertensive effectAm J Cardiovasc Drugs200551718315901205
   PubMedGoogle Scholar
• MizunoMSadaTIkedaMPharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonistEur J Pharmacol199528518188566137
   PubMed Web of Science ®Google Scholar
• NeutelJMClinical studies of CS-866, the newest angiotensin II receptor antagonistAm J Cardiol200187Suppl37C43C
   PubMedGoogle Scholar
• NeutelJMSaundersEBakrisGLThe efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trialJ Clin Hypertens (Greenwich)200575788616227760
   PubMedGoogle Scholar
• NeutelJMSmithDHSilfaniTNEffects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertensionJ Hum Hypertens2006202556216397514
   PubMed Web of Science ®Google Scholar
• NeutelJSmithDWeberMAUse of olmesartan medoxomil-based treatment algorithm for hypertension controlJ Clin Hypertens (Greenwich)200461687415073470
   PubMedGoogle Scholar
• PugsleyMA characterization of the molecular interactions of olmesartan (OLM) and telmisartan (TEL) with human angiotensin AT1 receptors [abstract]2006American Society of Hypertension 21st Annual Scientific MeetingNew York, NY
   Google Scholar
• QuanAChavanuKMerkelJA review of the efficacy of fixed-dose combinations olmesartan medoxomil/hydrochlorothiazide and amlodipine besylate/benazepril in factorial design studiesAm J Cardiovasc Drugs200661031316555863
   PubMedGoogle Scholar
• RamCVAntihypertensive efficacy of angiotensin receptor blockers in combination with hydrochlorothiazide: a review of the factorial-design studiesJ Clin Hypertens (Greenwich)200465697715470286
   PubMedGoogle Scholar
• ReyesADiuretics in the therapy of hypertensionJ Hum Hypertens200216Suppl 1S788311986901
   PubMedGoogle Scholar
• RumpLCAmbrosioniEBurnierMInitial combination therapy with olmesartan/hydrochlorothiazide in moderate-to-severe hypertensionJ Hum Hypertens20062029930116452995
   PubMed Web of Science ®Google Scholar
• SachseAVerboomCNJagerBEfficacy of eprosartan in combination with HCTZ in patients with essential hypertensionJ Hum Hypertens2002161697611896506
   PubMed Web of Science ®Google Scholar
• SchwochoLRMasonsonHNPharmacokinetics of CS-866, a new angiotensin II receptor blocker, in healthy subjectsJ Clin Pharmacol2001415152711361048
   PubMed Web of Science ®Google Scholar
• SellinLStegbauerJLaeisPAdding hydrochlorothiazide to olmesartan dose dependently improves 24-h blood pressure and response rates in mild-to-moderate hypertensionJ Hypertens20052320839216208152
   PubMed Web of Science ®Google Scholar
• SingerGMIzharMBlackHRGoal-oriented hypertension management: translating clinical trials to practiceHypertension200240464912364348
   PubMed Web of Science ®Google Scholar
• SwalesJDCurrent clinical practice in hypertension: the EISBERG (Evaluation and Interventions for Systolic Blood pressure Elevation-Regional and Global) projectAm Heart J1999138231710467218
   PubMed Web of Science ®Google Scholar
• SweetmanSCMartindale: the complete drug reference2005LondonPharmaceutical Press
   Google Scholar
• WhitworthJA2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertensionJ Hypertens20032119839214597836
   PubMed Web of Science ®Google Scholar